首页 | 本学科首页   官方微博 | 高级检索  
检索        

主要组织相容性复合物在特发性炎性肌病中的表达及临床应用价值
引用本文:卢昕,谢瑶,王国春,王泰玲,王跃.主要组织相容性复合物在特发性炎性肌病中的表达及临床应用价值[J].中华风湿病学杂志,2008,12(6).
作者姓名:卢昕  谢瑶  王国春  王泰玲  王跃
作者单位:1. 卫生部中日友好医院风湿免疫科,北京,100029
2. 卫生部中日友好医院风湿病理科,北京,100029
基金项目:国家自然科学基金,中日友好医院重点学科资助项目 
摘    要:目的 研究多发性肌炎(PM)和皮肌炎(DM)患者骨骼肌组织中的主要组织相容性复合物(MHC)的表达,探讨它们在特发性炎性肌病(IIM)发病机制中的作用及临床应用价值.方法 选取我院1986-2007年风湿免疫科收住的IIM患者骨骼肌组织标本45例(PM 19例,DM 26例),以性别、年龄相匹配的外伤患者骨骼肌标本30例作为对照.用免疫组织化学方法检测人类白细胞抗原(HIA)-A/B/C(即MHC-Ⅰ分子)和HLA-DR(即MHC-Ⅱ分子)在PM/DM患者及对照组肌组织中的表达.结果 HLA-A/B/C在18例PM、24例DM和3例对照组肌组织中有表达,阳性率分别为95%、92%和10%;HLA-DR在PM组、DM组和对照组肌组织中的阳性表达率分别为84%、81%和13%.HLA-A/B/C和HLA-DR在PM/DM患者肌组织中的表达量均较正常对照组明显升高(P均<0.05),但在PM组和DM组间差异无统计学意义(P均>0.05).根据组织病理学特点把PM/DM患者分为病变程度不同的3组,HLA-A/B/C和HLA-DR在PM/DM患者肌组织中的表达量与肌纤维变性、坏死、炎症浸润的程度和各项临床及实验室指标无明显关联(P均>0.05).结论 MHC-Ⅰ和Ⅱ类分子在PM/DM患者肌肉组织中表达增高,在无明显炎症浸润和肌纤维坏死的患者中也可见到这种表达的上调,检测肌组织中MHC-Ⅰ和Ⅱ类分子的表达可用于PM/DM的诊断.

关 键 词:多发性肌炎  皮肌炎  主要组织相容性复合物

The expression of major histocompatibility complex in idiopathic inflammatory myopathies and its clinical application
LU Xin,XIE Yao,WANG Guo-chun,WANG Tai-lin,WANG Yue.The expression of major histocompatibility complex in idiopathic inflammatory myopathies and its clinical application[J].Chinese Journal of Rheumatology,2008,12(6).
Authors:LU Xin  XIE Yao  WANG Guo-chun  WANG Tai-lin  WANG Yue
Abstract:Objective To study the expression of major histocompatibility complex(MHC)on muscle biopsy specimens of idiopathic inflammatory myopathies(IIM),and assess diagnostic value of MHC in IIM. Methods Forty-five patients with IIM(19 polymyositis and 26 dermatomyositis)were selected for this study.Thirty healthy subjects were included as controls.Immunohistochemical staining was applied to identify the expression of HLA-A/B/C and HLA-DR on muscle biopsy-specimens in polymyositis (PM)/deFmatomyosiris (DM) patients and healthy controls.Results HIA-A/B/C antigens were expressed in muscle fibers in 18 out of 19 PM patients(95%),24 out of 26 DM patients(92%) and 3 out 0f 30 healthy controls(10%) respectively.The positive expression rate of HLA-DR in PM,DM patients and healthy controls were 84%, 81%,13%,respectively.The expressions of HLA-A/B/C and HLA-DR were significantly increased in PM and DM patients than those in healthy controls(both P<0.05),but no significant differences were found between PM and DM groups(both P>0.05).No significant correlations were demonstrated between the over-expression of HLA-A/B/C or HLA-DR and the extent of inflammatory infiltrations,muscle damage or clinical features in PM/DM groups (all P values>0.05).Conclusion MHC-Ⅰ and MHC-Ⅱover-expression in muscle fibers are the early events in PM and DM,and may occur in the absence of lymphocyte infihration and muscle damage.Immunostaining for MHC-Ⅰ and MHC-Ⅱcan be used as a routine test in the diagnosis of PM and DM.
Keywords:Polymyositis  Dermatomyositis  Major histocompatibility complex
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号